Logo image of ALGAE.PA

FERMENTALG (ALGAE.PA) Stock Fundamental Analysis

EPA:ALGAE - Euronext Paris - Matif - FR0011271600 - Common Stock - Currency: EUR

0.372  +0 (+0.54%)

Fundamental Rating

3

ALGAE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 63 industry peers in the Chemicals industry. ALGAE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ALGAE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALGAE has reported negative net income.
In the past year ALGAE has reported a negative cash flow from operations.
In the past 5 years ALGAE always reported negative net income.
ALGAE had a negative operating cash flow in each of the past 5 years.
ALGAE.PA Yearly Net Income VS EBIT VS OCF VS FCFALGAE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

ALGAE has a worse Return On Assets (-25.05%) than 80.95% of its industry peers.
ALGAE has a worse Return On Equity (-36.20%) than 74.60% of its industry peers.
Industry RankSector Rank
ROA -25.05%
ROE -36.2%
ROIC N/A
ROA(3y)-18.86%
ROA(5y)-24.61%
ROE(3y)-27.99%
ROE(5y)-42.19%
ROIC(3y)N/A
ROIC(5y)N/A
ALGAE.PA Yearly ROA, ROE, ROICALGAE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

ALGAE's Gross Margin of 14.04% is on the low side compared to the rest of the industry. ALGAE is outperformed by 71.43% of its industry peers.
In the last couple of years the Gross Margin of ALGAE has declined.
ALGAE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-35.61%
GM growth 5YN/A
ALGAE.PA Yearly Profit, Operating, Gross MarginsALGAE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K -5K

More info and screens

4

2. Health

2.1 Basic Checks

ALGAE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALGAE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALGAE has been increased compared to 5 years ago.
ALGAE has a worse debt/assets ratio than last year.
ALGAE.PA Yearly Shares OutstandingALGAE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ALGAE.PA Yearly Total Debt VS Total AssetsALGAE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

ALGAE has an Altman-Z score of 0.96. This is a bad value and indicates that ALGAE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.96, ALGAE is doing worse than 73.02% of the companies in the same industry.
A Debt/Equity ratio of 0.22 indicates that ALGAE is not too dependend on debt financing.
ALGAE has a Debt to Equity ratio of 0.22. This is in the better half of the industry: ALGAE outperforms 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACCN/A
WACC5.75%
ALGAE.PA Yearly LT Debt VS Equity VS FCFALGAE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 3.67 indicates that ALGAE has no problem at all paying its short term obligations.
ALGAE has a Current ratio of 3.67. This is amongst the best in the industry. ALGAE outperforms 87.30% of its industry peers.
ALGAE has a Quick Ratio of 3.42. This indicates that ALGAE is financially healthy and has no problem in meeting its short term obligations.
ALGAE's Quick ratio of 3.42 is amongst the best of the industry. ALGAE outperforms 93.65% of its industry peers.
Industry RankSector Rank
Current Ratio 3.67
Quick Ratio 3.42
ALGAE.PA Yearly Current Assets VS Current LiabilitesALGAE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

ALGAE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.17%.
The Revenue has grown by 69.31% in the past year. This is a very strong growth!
The Revenue has been growing by 75.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.03%
Revenue 1Y (TTM)69.31%
Revenue growth 3Y22.55%
Revenue growth 5Y75.18%
Sales Q2Q%170.04%

3.2 Future

The Earnings Per Share is expected to grow by 15.34% on average over the next years. This is quite good.
Based on estimates for the next years, ALGAE will show a very strong growth in Revenue. The Revenue will grow by 68.23% on average per year.
EPS Next Y52.08%
EPS Next 2Y30.7%
EPS Next 3Y22.85%
EPS Next 5Y15.34%
Revenue Next Year193.76%
Revenue Next 2Y107.07%
Revenue Next 3Y91.29%
Revenue Next 5Y68.23%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALGAE.PA Yearly Revenue VS EstimatesALGAE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20M 40M 60M 80M 100M
ALGAE.PA Yearly EPS VS EstimatesALGAE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALGAE. In the last year negative earnings were reported.
Also next year ALGAE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALGAE.PA Price Earnings VS Forward Price EarningsALGAE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALGAE.PA Per share dataALGAE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as ALGAE's earnings are expected to grow with 22.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.7%
EPS Next 3Y22.85%

More info and screens

0

5. Dividend

5.1 Amount

ALGAE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FERMENTALG

EPA:ALGAE (3/7/2025, 7:00:00 PM)

0.372

+0 (+0.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-03 2024-10-03
Earnings (Next)03-20 2025-03-20/amc
Inst Owners25.99%
Inst Owner ChangeN/A
Ins Owners2.11%
Ins Owner ChangeN/A
Market Cap32.06M
Analysts84.44
Price Target0.61 (63.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)13.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.54%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.99
P/FCF N/A
P/OCF N/A
P/B 0.82
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.09
BVpS0.45
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.05%
ROE -36.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.04%
FCFM N/A
ROA(3y)-18.86%
ROA(5y)-24.61%
ROE(3y)-27.99%
ROE(5y)-42.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-35.61%
GM growth 5YN/A
F-Score3
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.41%
Cap/Sales 6.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.67
Quick Ratio 3.42
Altman-Z 0.96
F-Score3
WACC5.75%
ROIC/WACCN/A
Cap/Depr(3y)114.7%
Cap/Depr(5y)105.41%
Cap/Sales(3y)21.78%
Cap/Sales(5y)42.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.03%
EPS Next Y52.08%
EPS Next 2Y30.7%
EPS Next 3Y22.85%
EPS Next 5Y15.34%
Revenue 1Y (TTM)69.31%
Revenue growth 3Y22.55%
Revenue growth 5Y75.18%
Sales Q2Q%170.04%
Revenue Next Year193.76%
Revenue Next 2Y107.07%
Revenue Next 3Y91.29%
Revenue Next 5Y68.23%
EBIT growth 1Y-24.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30%
EBIT Next 3Y30.06%
EBIT Next 5Y19.23%
FCF growth 1Y59.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.19%
OCF growth 3YN/A
OCF growth 5YN/A